In Vitro Diagnostics Market Size,  Analysis, Share, Trends, Size, & Forecast From 2023-2028

In Vitro Diagnostics Market Size, Analysis, Share, Trends, Size, & Forecast From 2023-2028
Report Category: Pharma and Healthcare
SKU: PMR-119324  Published Date: 2023-10-02   Pages:130   Delivery Format:


CHOOSE LICENSE TYPE





PMR Research.

Market Executive Summary

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report? we counted In-Vitro Diagnostics reagent.

Market Analysis and Insights: Global In-Vitro Diagnostics Market

Global In-Vitro Diagnostics market is expected to reach to US$ 97070 million in 2023, with a positive growth of %, compared with US$ 105140 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, In-Vitro Diagnostics industry is evaluated to reach US$ 130080 million in 2029. The CAGR will be 5.0% during 2023 to 2029.

The concentration of the market is relatively high, and the top  10 companies include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Becton Dickinson, BioMerieux, Sysmex, Hologic, Ortho Clinical Diagnostics, they occupied about 70% of whole market. North America dominates the market which occupied 41.39% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 15.74% of the whole market.

Report Covers:

This report presents an overview of global In-Vitro Diagnostics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global In-Vitro Diagnostics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted. 

Companies, Type, Application and Regions Listed in the Report:

By Company

    Roche

    Abbott

    Danaher

    Siemens Healthineers

    Thermo Fisher Scientific

    Sysmex

    BioMerieux

    Ortho Clinical Diagnostics

    Becton Dickinson

    Bio-Rad Laboratories

    Hologic

    LifeScan

    Qiagen

    Wuhan Easy Diagnosis

    Wondfo

    KHB

    Hotgen

    Mindray

    Sinocare

    Getein Biotech

Segment by Type

    Tissue Diagnostics

    Professional Diagnostic

    Molecular Diagnostic

    Diabetes Monitoring

    Other

Segment by Application

    Diabetes

    Infectious Diseases

    Oncology

    Cardiology

    HIV

    Other

By Region

    North America


        United States

        Canada

    Europe

        Germany

        France

        UK

        Italy

        Russia

        Nordic Countries

        Rest of Europe

    China

    Asia (excluding China)

        Japan

        South Korea

        China Taiwan

       Southeast Asia

        India

    Latin America, Middle East & Africa

        Brazil

        Mexico

        Turkey

        Israel

        GCC Countries

Chapter Outline

Chapter 1: Product definition, type and application introduction

Chapter 2: Regional revenue analysis from 2018 to 2029

Chapter 3: Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Product revenue analysis by type from 2018 to 2029 globally

Chapter 5: Product revenue analysis by application from 2018 to 2029 globally

Chapter 6: Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029

Chapter 7: Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029

Chapter 8: Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029

Chapter 9: Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029

Chapter 10: Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.

Chapter 11: Companies’ outline, covering company’s basic information, major business, In-Vitro Diagnostics introduction, etc. In-Vitro Diagnostics Revenue and Gross Margin of each company from 2018 to 2023

Chapter 12: Conclusions of In-Vitro Diagnostics

Chapter 13: Methodology and Data Sources



Table of Contents

1 Report Overview

    1.1 Study Scope

    1.2 Market Analysis by Type

        1.2.1 Global In-Vitro Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

        1.2.2 Tissue Diagnostics

        1.2.3 Professional Diagnostic

        1.2.4 Molecular Diagnostic

        1.2.5 Diabetes Monitoring

        1.2.6 Other

    1.3 Market by Application

        1.3.1 Global In-Vitro Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

        1.3.2 Diabetes

        1.3.3 Infectious Diseases

        1.3.4 Oncology

        1.3.5 Cardiology

        1.3.6 HIV

        1.3.7 Other

    1.4 Assumptions and Limitations

    1.5 Study Objectives

    1.6 Years Considered

 2 Global Growth Trends

    2.1 Global In-Vitro Diagnostics Market Perspective (2018-2029)

    2.2 Global In-Vitro Diagnostics Growth Trends by Region

        2.2.1 In-Vitro Diagnostics Market Size by Region: 2018 VS 2022 VS 2029

        2.2.2 In-Vitro Diagnostics Historic Market Size by Region (2018-2023)

        2.2.3 In-Vitro Diagnostics Forecasted Market Size by Region (2024-2029)

    2.3 In-Vitro Diagnostics Market Dynamics

        2.3.1 In-Vitro Diagnostics Industry Trends

        2.3.2 In-Vitro Diagnostics Market Drivers

        2.3.3 In-Vitro Diagnostics Market Challenges

        2.3.4 In-Vitro Diagnostics Market Restraints

 3 Competition Landscape by Key Players

    3.1 Global Revenue In-Vitro Diagnostics by Players

        3.1.1 Global In-Vitro Diagnostics Revenue by Players (2018-2023)

        3.1.2 Global In-Vitro Diagnostics Revenue Market Share by Players (2018-2023)

    3.2 Global In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

    3.3 Global Key Players of In-Vitro Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023

    3.4 Global In-Vitro Diagnostics Market Concentration Ratio

        3.4.1 Global In-Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)

        3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostics Revenue in 2022

    3.5 Global Key Players of In-Vitro Diagnostics Head office and Area Served

    3.6 Global Key Players of In-Vitro Diagnostics, Product and Application

    3.7 Global Key Players of In-Vitro Diagnostics, Date of Enter into This Industry

    3.8 Mergers & Acquisitions, Expansion Plans

 4 In-Vitro Diagnostics Breakdown Data by Type

    4.1 Global In-Vitro Diagnostics Historic Market Size by Type (2018-2023)

    4.2 Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2029)

 5 In-Vitro Diagnostics Breakdown Data by Application

    5.1 Global In-Vitro Diagnostics Historic Market Size by Application (2018-2023)

    5.2 Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2029)

 6 North America

    6.1 North America In-Vitro Diagnostics Market Size (2018-2029)

    6.2 North America In-Vitro Diagnostics Market Size by Type

        6.2.1 North America In-Vitro Diagnostics Market Size by Type (2018-2023)

        6.2.2 North America In-Vitro Diagnostics Market Size by Type (2024-2029)

        6.2.3 North America In-Vitro Diagnostics Market Share by Type (2018-2029)

    6.3 North America In-Vitro Diagnostics Market Size by Application

        6.3.1 North America In-Vitro Diagnostics Market Size by Application (2018-2023)

        6.3.2 North America In-Vitro Diagnostics Market Size by Application (2024-2029)

        6.3.3 North America In-Vitro Diagnostics Market Share by Application (2018-2029)

    6.4 North America In-Vitro Diagnostics Market Size by Country

        6.4.1 North America In-Vitro Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

        6.4.2 North America In-Vitro Diagnostics Market Size by Country (2018-2023)

        6.4.3 North America In-Vitro Diagnostics Market Size by Country (2024-2029)

        6.4.4 United States

        6.4.5 Canada

 7 Europe

    7.1 Europe In-Vitro Diagnostics Market Size (2018-2029)

    7.2 Europe In-Vitro Diagnostics Market Size by Type

        7.2.1 Europe In-Vitro Diagnostics Market Size by Type (2018-2023)

        7.2.2 Europe In-Vitro Diagnostics Market Size by Type (2024-2029)

        7.2.3 Europe In-Vitro Diagnostics Market Share by Type (2018-2029)

    7.3 Europe In-Vitro Diagnostics Market Size by Application

        7.3.1 Europe In-Vitro Diagnostics Market Size by Application (2018-2023)

        7.3.2 Europe In-Vitro Diagnostics Market Size by Application (2024-2029)

        7.3.3 Europe In-Vitro Diagnostics Market Share by Application (2018-2029)

    7.4 Europe In-Vitro Diagnostics Market Size by Country

        7.4.1 Europe In-Vitro Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

        7.4.2 Europe In-Vitro Diagnostics Market Size by Country (2018-2023)

        7.4.3 Europe In-Vitro Diagnostics Market Size by Country (2024-2029)

        7.4.3 Germany

        7.4.4 France

        7.4.5 U.K.

        7.4.6 Italy

        7.4.7 Russia

        7.4.8 Nordic Countries

 8 China

    8.1 China In-Vitro Diagnostics Market Size (2018-2029)

    8.2 China In-Vitro Diagnostics Market Size by Type

        8.2.1 China In-Vitro Diagnostics Market Size by Type (2018-2023)

        8.2.2 China In-Vitro Diagnostics Market Size by Type (2024-2029)

        8.2.3 China In-Vitro Diagnostics Market Share by Type (2018-2029)

    8.3 China In-Vitro Diagnostics Market Size by Application

        8.3.1 China In-Vitro Diagnostics Market Size by Application (2018-2023)

        8.3.2 China In-Vitro Diagnostics Market Size by Application (2024-2029)

        8.3.3 China In-Vitro Diagnostics Market Share by Application (2018-2029)

 9 Asia (excluding China)

    9.1 Asia In-Vitro Diagnostics Market Size (2018-2029)

    9.2 Asia In-Vitro Diagnostics Market Size by Type

        9.2.1 Asia In-Vitro Diagnostics Market Size by Type (2018-2023)

        9.2.2 Asia In-Vitro Diagnostics Market Size by Type (2024-2029)

        9.2.3 Asia In-Vitro Diagnostics Market Share by Type (2018-2029)

    9.3 Asia In-Vitro Diagnostics Market Size by Application

        9.3.1 Asia In-Vitro Diagnostics Market Size by Application (2018-2023)

        9.3.2 Asia In-Vitro Diagnostics Market Size by Application (2024-2029)

        9.3.3 Asia In-Vitro Diagnostics Market Share by Application (2018-2029)

    9.4 Asia In-Vitro Diagnostics Market Size by Region

        9.4.1 Asia In-Vitro Diagnostics Market Size by Region: 2018 VS 2022 VS 2029

        9.4.2 Asia In-Vitro Diagnostics Market Size by Region (2018-2023)

        9.4.3 Asia In-Vitro Diagnostics Market Size by Region (2024-2029)

        9.4.4 Japan

        9.4.5 South Korea

        9.4.6 China Taiwan

        9.4.7 Southeast Asia

        9.4.8 India

        9.4.9 Australia

 10 Middle East, Africa, and Latin America

    10.1 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size (2018-2029)

    10.2 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Type

        10.2.1 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Type (2018-2023)

        10.2.2 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Type (2024-2029)

        10.2.3 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Share by Type (2018-2029)

    10.3 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Application

        10.3.1 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Application (2018-2023)

        10.3.2 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Application (2024-2029)

        10.3.3 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Share by Application (2018-2029)

    10.4 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country

        10.4.1 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country: 2018 VS 2022 VS 2029

        10.4.2 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country (2018-2023)

        10.4.3 Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country (2024-2029)

        10.4.4 Brazil

        10.4.5 Mexico

        10.4.6 Turkey

        10.4.7 Saudi Arabia

        10.4.8 Israel

        10.4.9 GCC Countries

 11 Key Players Profiles

    11.1 Roche

        11.1.1 Roche Company Details

        11.1.2 Roche Business Overview

        11.1.3 Roche In-Vitro Diagnostics Introduction

        11.1.4 Roche Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.1.5 Roche Recent Developments

    11.2 Abbott

        11.2.1 Abbott Company Details

        11.2.2 Abbott Business Overview

        11.2.3 Abbott In-Vitro Diagnostics Introduction

        11.2.4 Abbott Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.2.5 Abbott Recent Developments

    11.3 Danaher

        11.3.1 Danaher Company Details

        11.3.2 Danaher Business Overview

        11.3.3 Danaher In-Vitro Diagnostics Introduction

        11.3.4 Danaher Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.3.5 Danaher Recent Developments

    11.4 Siemens Healthineers

        11.4.1 Siemens Healthineers Company Details

        11.4.2 Siemens Healthineers Business Overview

        11.4.3 Siemens Healthineers In-Vitro Diagnostics Introduction

        11.4.4 Siemens Healthineers Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.4.5 Siemens Healthineers Recent Developments

    11.5 Thermo Fisher Scientific

        11.5.1 Thermo Fisher Scientific Company Details

        11.5.2 Thermo Fisher Scientific Business Overview

        11.5.3 Thermo Fisher Scientific In-Vitro Diagnostics Introduction

        11.5.4 Thermo Fisher Scientific Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.5.5 Thermo Fisher Scientific Recent Developments

    11.6 Sysmex

        11.6.1 Sysmex Company Details

        11.6.2 Sysmex Business Overview

        11.6.3 Sysmex In-Vitro Diagnostics Introduction

        11.6.4 Sysmex Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.6.5 Sysmex Recent Developments

    11.7 BioMerieux

        11.7.1 BioMerieux Company Details

        11.7.2 BioMerieux Business Overview

        11.7.3 BioMerieux In-Vitro Diagnostics Introduction

        11.7.4 BioMerieux Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.7.5 BioMerieux Recent Developments

    11.8 Ortho Clinical Diagnostics

        11.8.1 Ortho Clinical Diagnostics Company Details

        11.8.2 Ortho Clinical Diagnostics Business Overview

        11.8.3 Ortho Clinical Diagnostics In-Vitro Diagnostics Introduction

        11.8.4 Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.8.5 Ortho Clinical Diagnostics Recent Developments

    11.9 Becton Dickinson

        11.9.1 Becton Dickinson Company Details

        11.9.2 Becton Dickinson Business Overview

        11.9.3 Becton Dickinson In-Vitro Diagnostics Introduction

        11.9.4 Becton Dickinson Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.9.5 Becton Dickinson Recent Developments

    11.10 Bio-Rad Laboratories

        11.10.1 Bio-Rad Laboratories Company Details

        11.10.2 Bio-Rad Laboratories Business Overview

        11.10.3 Bio-Rad Laboratories In-Vitro Diagnostics Introduction

        11.10.4 Bio-Rad Laboratories Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.10.5 Bio-Rad Laboratories Recent Developments

    11.11 Hologic

        11.11.1 Hologic Company Details

        11.11.2 Hologic Business Overview

        11.11.3 Hologic In-Vitro Diagnostics Introduction

        11.11.4 Hologic Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.11.5 Hologic Recent Developments

    11.12 LifeScan

        11.12.1 LifeScan Company Details

        11.12.2 LifeScan Business Overview

        11.12.3 LifeScan In-Vitro Diagnostics Introduction

        11.12.4 LifeScan Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.12.5 LifeScan Recent Developments

    11.13 Qiagen

        11.13.1 Qiagen Company Details

        11.13.2 Qiagen Business Overview

        11.13.3 Qiagen In-Vitro Diagnostics Introduction

        11.13.4 Qiagen Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.13.5 Qiagen Recent Developments

    11.14 Wuhan Easy Diagnosis

        11.14.1 Wuhan Easy Diagnosis Company Details

        11.14.2 Wuhan Easy Diagnosis Business Overview

        11.14.3 Wuhan Easy Diagnosis In-Vitro Diagnostics Introduction

        11.14.4 Wuhan Easy Diagnosis Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.14.5 Wuhan Easy Diagnosis Recent Developments

    11.15 Wondfo

        11.15.1 Wondfo Company Details

        11.15.2 Wondfo Business Overview

        11.15.3 Wondfo In-Vitro Diagnostics Introduction

        11.15.4 Wondfo Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.15.5 Wondfo Recent Developments

    11.16 KHB

        11.16.1 KHB Company Details

        11.16.2 KHB Business Overview

        11.16.3 KHB In-Vitro Diagnostics Introduction

        11.16.4 KHB Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.16.5 KHB Recent Developments

    11.17 Hotgen

        11.17.1 Hotgen Company Details

        11.17.2 Hotgen Business Overview

        11.17.3 Hotgen In-Vitro Diagnostics Introduction

        11.17.4 Hotgen Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.17.5 Hotgen Recent Developments

    11.18 Mindray

        11.18.1 Mindray Company Details

        11.18.2 Mindray Business Overview

        11.18.3 Mindray In-Vitro Diagnostics Introduction

        11.18.4 Mindray Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.18.5 Mindray Recent Developments

    11.19 Sinocare

        11.19.1 Sinocare Company Details

        11.19.2 Sinocare Business Overview

        11.19.3 Sinocare In-Vitro Diagnostics Introduction

        11.19.4 Sinocare Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.19.5 Sinocare Recent Developments

    11.20 Getein Biotech

        11.20.1 Getein Biotech Company Details

        11.20.2 Getein Biotech Business Overview

        11.20.3 Getein Biotech In-Vitro Diagnostics Introduction

        11.20.4 Getein Biotech Revenue in In-Vitro Diagnostics Business (2018-2023)

        11.20.5 Getein Biotech Recent Developments

 12 Analyst's Viewpoints/Conclusions

 13 Appendix

    13.1 Research Methodology

        13.1.1 Methodology/Research Approach

        13.1.2 Data Source

    13.2 Disclaimer

    13.3 Author Details



List of Figures

List of Tables

    Table 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

    Table 2. Key Players of Tissue Diagnostics

    Table 3. Key Players of Professional Diagnostic

    Table 4. Key Players of Molecular Diagnostic

    Table 5. Key Players of Diabetes Monitoring

    Table 6. Key Players of Other

    Table 7. Global In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

    Table 8. Global In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global In-Vitro Diagnostics Market Share by Region (2018-2023)

    Table 11. Global In-Vitro Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global In-Vitro Diagnostics Market Share by Region (2024-2029)

    Table 13. In-Vitro Diagnostics Market Trends

    Table 14. In-Vitro Diagnostics Market Drivers

    Table 15. In-Vitro Diagnostics Market Challenges

    Table 16. In-Vitro Diagnostics Market Restraints

    Table 17. Global In-Vitro Diagnostics Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global In-Vitro Diagnostics Revenue Share by Players (2018-2023)

    Table 19. Global Top In-Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2022)

    Table 20. Global In-Vitro Diagnostics Industry Ranking 2021 VS 2022 VS 2023

    Table 21. Global 5 Largest Players Market Share by In-Vitro Diagnostics Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Global Key Players of In-Vitro Diagnostics, Headquarters and Area Served

    Table 23. Global Key Players of In-Vitro Diagnostics, Product and Application

    Table 24. Global Key Players of In-Vitro Diagnostics, Product and Application

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global In-Vitro Diagnostics Revenue Market Share by Type (2018-2023)

    Table 28. Global In-Vitro Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global In-Vitro Diagnostics Revenue Market Share by Type (2024-2029)

    Table 30. Global In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global In-Vitro Diagnostics Revenue Share by Application (2018-2023)

    Table 32. Global In-Vitro Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global In-Vitro Diagnostics Revenue Share by Application (2024-2029)

    Table 34. North America In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)

    Table 35. North America In-Vitro Diagnostics Market Size by Type (2024-2029) & (US$ Million)

    Table 36. North America In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)

    Table 37. North America In-Vitro Diagnostics Market Size by Application (2024-2029) & (US$ Million)

    Table 38. North America In-Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 39. North America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 40. North America In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 41. Europe In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)

    Table 42. Europe In-Vitro Diagnostics Market Size by Type (2024-2029) & (US$ Million)

    Table 43. Europe In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)

    Table 44. Europe In-Vitro Diagnostics Market Size by Application (2024-2029) & (US$ Million)

    Table 45. Europe In-Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Europe In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Europe In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 48. China In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)

    Table 49. China In-Vitro Diagnostics Market Size by Type (2024-2029) & (US$ Million)

    Table 50. China In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)

    Table 51. China In-Vitro Diagnostics Market Size by Application (2024-2029) & (US$ Million)

    Table 52. Asia In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)

    Table 53. Asia In-Vitro Diagnostics Market Size by Type (2024-2029) & (US$ Million)

    Table 54. Asia In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)

    Table 55. Asia In-Vitro Diagnostics Market Size by Application (2024-2029) & (US$ Million)

    Table 56. Asia In-Vitro Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 57. Asia In-Vitro Diagnostics Market Size by Region (2018-2023) & (US$ Million)

    Table 58. Asia In-Vitro Diagnostics Market Size by Region (2024-2029) & (US$ Million)

    Table 59. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Type (2018-2023) & (US$ Million)

    Table 60. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Type (2024-2029) & (US$ Million)

    Table 61. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Application (2018-2023) & (US$ Million)

    Table 62. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Application (2024-2029) & (US$ Million)

    Table 63. Middle East, Africa, and Latin America In-Vitro Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 64. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country (2018-2023) & (US$ Million)

    Table 65. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size by Country (2024-2029) & (US$ Million)

    Table 66. Roche Company Details

    Table 67. Roche Business Overview

    Table 68. Roche In-Vitro Diagnostics Product

    Table 69. Roche Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 70. Roche Recent Developments

    Table 71. Abbott Company Details

    Table 72. Abbott Business Overview

    Table 73. Abbott In-Vitro Diagnostics Product

    Table 74. Abbott Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 75. Abbott Recent Developments

    Table 76. Danaher Company Details

    Table 77. Danaher Business Overview

    Table 78. Danaher In-Vitro Diagnostics Product

    Table 79. Danaher Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 80. Danaher Recent Developments

    Table 81. Siemens Healthineers Company Details

    Table 82. Siemens Healthineers Business Overview

    Table 83. Siemens Healthineers In-Vitro Diagnostics Product

    Table 84. Siemens Healthineers Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 85. Siemens Healthineers Recent Developments

    Table 86. Thermo Fisher Scientific Company Details

    Table 87. Thermo Fisher Scientific Business Overview

    Table 88. Thermo Fisher Scientific In-Vitro Diagnostics Product

    Table 89. Thermo Fisher Scientific Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 90. Thermo Fisher Scientific Recent Developments

    Table 91. Sysmex Company Details

    Table 92. Sysmex Business Overview

    Table 93. Sysmex In-Vitro Diagnostics Product

    Table 94. Sysmex Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 95. Sysmex Recent Developments

    Table 96. BioMerieux Company Details

    Table 97. BioMerieux Business Overview

    Table 98. BioMerieux In-Vitro Diagnostics Product

    Table 99. BioMerieux Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 100. BioMerieux Recent Developments

    Table 101. Ortho Clinical Diagnostics Company Details

    Table 102. Ortho Clinical Diagnostics Business Overview

    Table 103. Ortho Clinical Diagnostics In-Vitro Diagnostics Product

    Table 104. Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 105. Ortho Clinical Diagnostics Recent Developments

    Table 106. Becton Dickinson Company Details

    Table 107. Becton Dickinson Business Overview

    Table 108. Becton Dickinson In-Vitro Diagnostics Product

    Table 109. Becton Dickinson Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 110. Becton Dickinson Recent Developments

    Table 111. Bio-Rad Laboratories Company Details

    Table 112. Bio-Rad Laboratories Business Overview

    Table 113. Bio-Rad Laboratories In-Vitro Diagnostics Product

    Table 114. Bio-Rad Laboratories Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 115. Bio-Rad Laboratories Recent Developments

    Table 116. Hologic Company Details

    Table 117. Hologic Business Overview

    Table 118. Hologic In-Vitro Diagnostics Product

    Table 119. Hologic Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 120. Hologic Recent Developments

    Table 121. LifeScan Company Details

    Table 122. LifeScan Business Overview

    Table 123. LifeScan In-Vitro Diagnostics Product

    Table 124. LifeScan Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 125. LifeScan Recent Developments

    Table 126. Qiagen Company Details

    Table 127. Qiagen Business Overview

    Table 128. Qiagen In-Vitro Diagnostics Product

    Table 129. Qiagen Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 130. Qiagen Recent Developments

    Table 131. Wuhan Easy Diagnosis Company Details

    Table 132. Wuhan Easy Diagnosis Business Overview

    Table 133. Wuhan Easy Diagnosis In-Vitro Diagnostics Product

    Table 134. Wuhan Easy Diagnosis Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 135. Wuhan Easy Diagnosis Recent Developments

    Table 136. Wondfo Company Details

    Table 137. Wondfo Business Overview

    Table 138. Wondfo In-Vitro Diagnostics Product

    Table 139. Wondfo Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 140. Wondfo Recent Developments

    Table 141. KHB Company Details

    Table 142. KHB Business Overview

    Table 143. KHB In-Vitro Diagnostics Product

    Table 144. KHB Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 145. KHB Recent Developments

    Table 146. Hotgen Company Details

    Table 147. Hotgen Business Overview

    Table 148. Hotgen In-Vitro Diagnostics Product

    Table 149. Hotgen Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 150. Hotgen Recent Developments

    Table 151. Mindray Company Details

    Table 152. Mindray Business Overview

    Table 153. Mindray In-Vitro Diagnostics Product

    Table 154. Mindray Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 155. Mindray Recent Developments

    Table 156. Sinocare Company Details

    Table 157. Sinocare Business Overview

    Table 158. Sinocare In-Vitro Diagnostics Product

    Table 159. Sinocare Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 160. Sinocare Recent Developments

    Table 161. Getein Biotech Company Details

    Table 162. Getein Biotech Business Overview

    Table 163. Getein Biotech In-Vitro Diagnostics Product

    Table 164. Getein Biotech Revenue in In-Vitro Diagnostics Business (2018-2023) & (US$ Million)

    Table 165. Getein Biotech Recent Developments

    Table 166. Research Programs/Design for This Report

    Table 167. Key Data Information from Secondary Sources

    Table 168. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 2. Global In-Vitro Diagnostics Market Share by Type: 2022 VS 2029

    Figure 3. Tissue Diagnostics Features

    Figure 4. Professional Diagnostic Features

    Figure 5. Molecular Diagnostic Features

    Figure 6. Diabetes Monitoring Features

    Figure 7. Other Features

    Figure 8. Global In-Vitro Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 9. Global In-Vitro Diagnostics Market Share by Application: 2022 VS 2029

    Figure 10. Diabetes Case Studies

    Figure 11. Infectious Diseases Case Studies

    Figure 12. Oncology Case Studies

    Figure 13. Cardiology Case Studies

    Figure 14. HIV Case Studies

    Figure 15. Other Case Studies

    Figure 16. In-Vitro Diagnostics Report Years Considered

    Figure 17. Global In-Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 18. Global In-Vitro Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 19. Global In-Vitro Diagnostics Market Share by Region: 2022 VS 2029

    Figure 20. Global In-Vitro Diagnostics Market Share by Players in 2022

    Figure 21. Global Top In-Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostics as of 2022)

    Figure 22. The Top 10 and 5 Players Market Share by In-Vitro Diagnostics Revenue in 2022

    Figure 23. North America In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. North America In-Vitro Diagnostics Market Share by Type (2018-2029)

    Figure 25. North America In-Vitro Diagnostics Market Share by Application (2018-2029)

    Figure 26. North America In-Vitro Diagnostics Market Share by Country (2018-2029)

    Figure 27. United States In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Canada In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Europe In-Vitro Diagnostics Market Size YoY (2018-2029) & (US$ Million)

    Figure 30. Europe In-Vitro Diagnostics Market Share by Type (2018-2029)

    Figure 31. Europe In-Vitro Diagnostics Market Share by Application (2018-2029)

    Figure 32. Europe In-Vitro Diagnostics Market Share by Country (2018-2029)

    Figure 33. Germany In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. France In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. U.K. In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Italy In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Russia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Nordic Countries In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. China In-Vitro Diagnostics Market Size YoY (2018-2029) & (US$ Million)

    Figure 40. China In-Vitro Diagnostics Market Share by Type (2018-2029)

    Figure 41. China In-Vitro Diagnostics Market Share by Application (2018-2029)

    Figure 42. Asia In-Vitro Diagnostics Market Size YoY (2018-2029) & (US$ Million)

    Figure 43. Asia In-Vitro Diagnostics Market Share by Type (2018-2029)

    Figure 44. Asia In-Vitro Diagnostics Market Share by Application (2018-2029)

    Figure 45. Asia In-Vitro Diagnostics Market Share by Region (2018-2029)

    Figure 46. Japan In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. South Korea In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. China Taiwan In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Southeast Asia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. India In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 51. Australia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 52. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Size YoY (2018-2029) & (US$ Million)

    Figure 53. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Share by Type (2018-2029)

    Figure 54. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Share by Application (2018-2029)

    Figure 55. Middle East, Africa, and Latin America In-Vitro Diagnostics Market Share by Country (2018-2029)

    Figure 56. Brazil In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 57. Mexico In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 58. Turkey In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 59. Saudi Arabia In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 60. Israel In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 61. GCC Countries In-Vitro Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 62. Roche Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 63. Abbott Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 64. Danaher Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 65. Siemens Healthineers Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 66. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 67. Sysmex Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 68. BioMerieux Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 69. Ortho Clinical Diagnostics Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 70. Becton Dickinson Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 71. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 72. Hologic Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 73. LifeScan Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 74. Qiagen Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 75. Wuhan Easy Diagnosis Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 76. Wondfo Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 77. KHB Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 78. Hotgen Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 79. Mindray Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 80. Sinocare Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 81. Getein Biotech Revenue Growth Rate in In-Vitro Diagnostics Business (2018-2023)

    Figure 82. Bottom-up and Top-down Approaches for This Report

    Figure 83. Data Triangulation

    Figure 84. Key Executives Interviewed


We can offer customized data and information to meet our clients need.

This report focuses on:

► Intelligent insights to take informed business decisions.

► Qualitative and quantitative analysis of the market.

► Market size and forecasts from 2024 to 2030.

► Opportunities for expansion and in-depth market analysis.

► Segmentation and regional revenue forecasts.

► Analysis of the market share and competitive landscape.

► Strategic recommendations for future growth.


You'll also receive:

► A comprehensive market research report in PDF or PPT formats.

► Access to our analysts to learn more about the report and get answers to your specific business questions.

► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.


Contact us today to learn more and get sample report.


Our Research Reports Look Like This
Pragma Market Research Sample

Covid-19 Impact Duns and Brad Badge
up